Vaccine Authorization

Dec 02, 2020

The UK has given emergency authorization for the SARS-CoV-2 vaccine from Pfizer and BioNTech, the Associated Press reports.

The firms announced last month that data from their late-stage clinical trial indicated their mRNA-based candidate vaccine has a 95 percent efficacy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Ancestry to Discontinue NGS-Based AncestryHealth Service
Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan
DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech
FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test
JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More
Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

The Scan

Germany to Increase Viral Sequencing

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

Getting Used to It

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

Green Access at Science

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

Science Papers Examine Chronic Kidney Disease GWAS, Pneumonia Microbiome

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.

Menu